credit facility

NEW YORK (GenomeWeb) – Bio-Rad Laboratories said on Thursday it has entered into a credit agreement with lenders to borrow up to $200 million.

NEW YORK (GenomeWeb) – Neuropsychiatric molecular diagnostics firm Assurex today said that it has secured a $25 million credit facility and $7 million in investments.
The funds will be used to increase clinical adoption of the Mason, Ohio-based firm's GeneSight products.

NEW YORK (GenomeWeb) – Biocept has entered into a $10 million loan and security agreement with Oxford Finance, the San Diego-based oncology diagnostics firm said in a US Securities and Exchange document on Tuesday.

NEW YORK (GenomeWeb News) – PerkinElmer said after the close of the market on Friday that it entered into an agreement to provide it a $700 million committed unsecured revolving credit facility through Jan. 8, 2019.

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific said after the close of the market on Friday that it has entered into a new $1.5 billion credit agreement, replacing the existing $1 billion revolving credit agreement.

NEW YORK (GenomeWeb News) – Transgenomic reported after the close of the market on Wednesday a 15 percent year over year drop in fourth-quarter revenues, driven primarily by a decline in its diagnostic tools segment.
The company also announced a new $8.0 million credit facility.

NEW YORK (GenomeWeb News) – Oxford Finance today said that it and Silicon Valley Bank have provided a $15 million senior credit facility for molecular diagnostics firm XDx.

NEW YORK (GenomeWeb News) – Waters said today in a document filed with the US Securities and Exchange Commission that it entered into an Incremental Commitment Agreement to increase its revolving facility to $900 million from $700 million.

NEW YORK (GenomeWeb News) – Quidel announced late on Friday it has entered into an amended and restated $140 million, five-year senior secured facility.
Bank of America is the sole lead arranger for the facility, while US Bank National Association is the syndication agent.